Related Experiment Videos
[Comments on the WHO Reference Center classification of non-Hodgkin hematosarcomas]
Annales D'Anatomie Pathologique
|July 1, 1976
Summary
This study reviews the World Health Organization's (WHO) classification for lymphatic and hematopoietic cancers, offering critiques and proposing parallel use of multiple systems, including Rappaport's nomenclature, for routine histopathology.
Area of Science:
- Hematology
- Oncology
- Pathology
Context:
- The World Health Organization (WHO) classification of neoplastic disorders of lymphatic and haematopoietic tissue is a critical tool in hematologic oncology.
- Previous classifications have been updated, necessitating a review of current standards.
Purpose:
- To critically evaluate the proposed WHO classification of neoplastic disorders of lymphatic and haematopoietic tissue.
- To address specific points of contention, such as the concept of reticulosarcoma.
- To propose practical approaches for routine histopathology.
Summary:
- The authors analyze the WHO classification for lymphatic and hematopoietic neoplasms, comparing it with other recent systems.
- Key criticisms are raised, particularly regarding the continued use of the term 'reticulosarcoma'.
- A recommendation is made for the parallel application of multiple classifications, including the established Rappaport nomenclature, in daily practice.
Impact:
- This work aims to refine diagnostic practices in hematopathology.
- It encourages a nuanced approach to cancer classification, acknowledging the evolution of the field.
- The proposed strategy seeks to improve consistency and accuracy in the histopathological diagnosis of lymphoid and hematopoietic malignancies.